Latest Insider Transactions at National Healthcare Corp (NHC)
This section provides a real-time view of insider transactions for National Healthcare Corp (NHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NATIONAL HEALTHCARE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NATIONAL HEALTHCARE CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2024
|
National Health Corp |
SELL
Open market or private sale
|
Direct |
28,147
-2.59%
|
$3,180,611
$113.71 P/Share
|
|
Dec 06
2024
|
Robert Michael Ussery President & COO |
SELL
Bona fide gift
|
Direct |
40
-0.03%
|
-
|
|
Dec 02
2024
|
Sandra Y. Trail Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+26.27%
|
$138,000
$69.19 P/Share
|
|
Sep 27
2024
|
W Andrew Adams Director |
SELL
Other acquisition or disposition
|
Indirect |
2,307
-100.0%
|
-
|
|
Sep 04
2024
|
Brian F Kidd SVP, Controller, PAO |
SELL
Open market or private sale
|
Direct |
2,000
-8.42%
|
$260,000
$130.01 P/Share
|
|
Aug 14
2024
|
Stephen Fowler Flatt CEO |
SELL
Open market or private sale
|
Direct |
3,907
-6.41%
|
$492,282
$126.54 P/Share
|
|
Aug 14
2024
|
James Paul Abernathy Director |
SELL
Open market or private sale
|
Direct |
1,605
-4.6%
|
$203,835
$127.0 P/Share
|
|
Aug 13
2024
|
Robert G Adams Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
3,000
+24.84%
|
$213,000
$71.64 P/Share
|
|
Jun 12
2024
|
Josh A Mc Creary Senior VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,799
-29.44%
|
$288,297
$103.61 P/Share
|
|
Jun 12
2024
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+29.61%
|
$212,000
$53.94 P/Share
|
|
Jun 12
2024
|
Robert Michael Ussery President & COO |
SELL
Bona fide gift
|
Direct |
2,350
-75.32%
|
-
|
|
Jun 11
2024
|
Robert Michael Ussery President & COO |
SELL
Bona fide gift
|
Direct |
50
-100.0%
|
-
|
|
May 31
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
760
-7.52%
|
$79,800
$105.75 P/Share
|
|
May 17
2024
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,776
-2.83%
|
$177,600
$100.4 P/Share
|
|
May 17
2024
|
Stephen Fowler Flatt CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+3.83%
|
$132,500
$53.94 P/Share
|
|
May 07
2024
|
W Andrew Adams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+2.78%
|
$577,500
$77.92 P/Share
|
|
May 03
2024
|
Emil E Hassan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.31%
|
$577,500
$77.92 P/Share
|
|
May 01
2024
|
Ernest G Burgess Iii Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
6,350
-6.86%
|
$584,200
$92.02 P/Share
|
|
May 01
2024
|
Ernest G Burgess Iii Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,500
+7.5%
|
$577,500
$77.92 P/Share
|
|
Apr 30
2024
|
Richard F Laroche Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,001
-1.47%
|
$270,090
$90.87 P/Share
|
|
Apr 30
2024
|
Richard F Laroche Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+100.0%
|
$577,500
$77.92 P/Share
|
|
Mar 12
2024
|
Robert Michael Ussery President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,257
-2.07%
|
$312,672
$96.48 P/Share
|
|
Mar 12
2024
|
Robert Michael Ussery President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+2.78%
|
$238,500
$53.94 P/Share
|
|
Mar 12
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,620
-20.59%
|
$251,520
$96.48 P/Share
|
|
Mar 12
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+22.68%
|
$197,849
$53.94 P/Share
|
|
Mar 12
2024
|
Brian F Kidd SVP, Controller, PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,807
-10.57%
|
$269,472
$96.48 P/Share
|
|
Mar 12
2024
|
Brian F Kidd SVP, Controller, PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+13.09%
|
$212,000
$53.94 P/Share
|
|
Mar 12
2024
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,810
-2.92%
|
$173,760
$96.48 P/Share
|
|
Mar 12
2024
|
Stephen Fowler Flatt CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+3.87%
|
$132,500
$53.94 P/Share
|
|
Mar 12
2024
|
Ben Anderson Sr Flatt Senior VP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,620
-17.81%
|
$251,520
$96.48 P/Share
|
|
Mar 12
2024
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+20.24%
|
$197,849
$53.94 P/Share
|
|
Mar 12
2024
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Payment of exercise price or tax liability
|
Direct |
2,620
-27.35%
|
$251,520
$96.48 P/Share
|
|
Mar 12
2024
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+28.04%
|
$197,849
$53.94 P/Share
|
|
Mar 05
2024
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
1,239
+10.14%
|
-
|
|
Mar 05
2024
|
Brian F Kidd SVP, Controller, PAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,409
+5.88%
|
-
|
|
Mar 05
2024
|
Robert Michael Ussery President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
2,563
+1.65%
|
-
|
|
Mar 05
2024
|
Stephen Fowler Flatt CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+4.47%
|
-
|
|
Mar 05
2024
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,375
+19.97%
|
-
|
|
Mar 05
2024
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Grant, award, or other acquisition
|
Direct |
1,018
+14.83%
|
-
|
|
Mar 05
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+10.66%
|
-
|
|
Feb 29
2024
|
Josh A Mc Creary Senior VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,911
-41.32%
|
$285,278
$98.66 P/Share
|
|
Feb 29
2024
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+34.64%
|
$235,179
$63.96 P/Share
|
|
Feb 27
2024
|
Ernest G Burgess Iii Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,000
+2.3%
|
$128,000
$64.64 P/Share
|
|
Feb 22
2024
|
Ben Anderson Sr Flatt Senior VP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,811
-22.4%
|
$281,100
$100.76 P/Share
|
|
Feb 22
2024
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+22.93%
|
$235,179
$63.96 P/Share
|
|
Feb 22
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,811
-26.2%
|
$281,100
$100.76 P/Share
|
|
Feb 22
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+25.81%
|
$235,179
$63.96 P/Share
|
|
Feb 22
2024
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,651
-6.04%
|
$365,100
$100.76 P/Share
|
|
Feb 22
2024
|
Stephen Fowler Flatt CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,733
+7.27%
|
$298,179
$63.96 P/Share
|
|
Feb 22
2024
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Payment of exercise price or tax liability
|
Direct |
2,811
-36.79%
|
$281,100
$100.76 P/Share
|